Novus Biologicals CCL11/Eotaxin Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Manufacturer: Novus Biologicals NBP177046PEP
DescriptionA blocking peptide containing 15 amino acids near the carboxy terminus of human Eotaxin. Source: Synthetic (Accession #: CAB07027) The CCL11/Eotaxin Blocking Peptide has been validated for the following applications: Antibody Competition.
|For blocking the activity of eotaxin, NBP1-77046|
|PBS pH 7.2 (10mM NAH2PO4, 10mM Na2HPO4, 130mM NaCl) containing 0.1% bovine serum albumin.|
|15 amino acids near the carboxy terminus of human Eotaxin|
|−20°C. Avoid freeze-thaw cycles.|